03Oct/13

Cellmid Limited receives federal research and development tax refund – Proactive Investors Australia


Proactive Investors Australia

Cellmid Limited receives federal research and development tax refund
Proactive Investors Australia
Recent studies have demonstrated that the company’s lead anti-midkine (MK) antibodies slowing primary tumour growth, reducing the spread of cancer and slowing the formation of blood vessels in different tumour types, which is a fundamental step in …
CELLMID LIMITED : R&D Tax refund received4-traders (press release)

all 3 news articles »